In addition, BDNF decreased TNF and β-amyloid peptide-induced cytotoxicity in cholinergic neurons by downregulating JNK activation through p38 MAPK, indicating possible therapeutic uses for Alzheimer’s disease [83]. The gene discussed is BDNF; the disease is Alzheimer disease.